Immunic, Inc. Announces Formation of Scientific-Medical Advisory Board
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunol…
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunol…
“The Helmholtz Innovation Labs open up our infrastructure to partners from business,” says Otmar D. Wiestler, President…
After receiving priority review in 2018, CIMZIA® (certolizumab pegol) is now approved in China for the treatment of Mode…
The German National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG today announced a collaboration to utiliz…
PROTAGEN AG, a leading provider of pharma development services, companion diagnostics and novel diagnostic tests in the…
Neovacs (Alternext Paris: ALNEV, PEA-eligible SMEs), a leader in active immunotherapy for the treatment of autoimmune di…
Wenn das Immunsystem körpereigene Strukturen bekämpft, können die Folgen verheerend sein. Besonders dann, wenn es sich g…
PROTAGEN AG, a leading specialist in the development of novel diagnostic tests and companion diagnostics in the autoimmu…
Protagen AG, a leading specialist in the development of novel diagnostic tests and companion diagnostics in the autoimmu…
Protagen AG, a leading specialist in the development of novel diagnostic tests and companion diagnostics in the autoimmu…